Stem Cells Market By Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery And Development), By Therapy (Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

Global Stem Cells Market by Products (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells and Very Small Embryonic Like Stem Cells) by Applications (Regenerative Medicine, Drug Discovery and Development) by Therapy (Autologous Stem Cells Therapy, Allogenic Stem Cells Therapy) - Market Growth, Future Prospects & Competitive Analysis, 2017 – 2025

To accelerate stem cell technology in perspective of drug discovery and development the pharmaceutical giants are currently focusing on integrating differentiation pathway discovery in non-human and human systems, stem cells training courses and institutional core facilities and developing stem cells gene tagged libraries. Additionally optimization of the cellular models and designs of stem cells employed are taking place with special focus on euploid, developmentally manipulative human models, probe mechanistic and phenotypic robustness of the natural genetic variation.

For the purpose of this study, the various products studied includes adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells. Adult stem cells are further classified as (neuronal stem cells, hematopoietic stem cells, mesenchymal stem cells, umbilical cord stem cells and others). The applications are classified as regenerative medicines and drug discovery and development. Regenerative medicines are further categorized as (neurology, orthopedics, oncology, hematology, cardiovascular diseases, diabetes, liver disorders and others). Therapy segment is further categorized as autologous stem cells therapy and allogenic stem cells therapy. Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global stem cells market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Rest of LATAM
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global stem cells market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global stem cells market. The key players profiled in this report are Advanced Cell Technology, Inc., BIOTIME, Inc., BrainStorm Cell Therapeutics, Caladrius, Cellartis AB, Celgene Corporation, CellGenix GmbH, Gamida Cell, Genea BioCells, Lonza, PromoCell GmbH, Pluristem, TiGenix and Waisman Biomanufacturing.

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions

Chapter 2. Executive Summary
2.1. Global Stem Cells Market Portraiture
2.2. Global Stem Cells Market, by Product, 2016 (US$ Mn)
2.3. Global Stem Cells Market, by Application, 2016 (US$ Mn)
2.4. Global Stem Cells Market, by Therapy, 2016 (US$ Mn)
2.5. Global Stem Cells Market Share, by Geography, 2016 (Value %)

Chapter 3. Stem Cells: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Driver 1
3.2.2. Driver 2
3.2.3. Driver 3
3.3. Challenges
3.3.1. Challenge 1
3.3.2. Challenge 2
3.4. Opportunities
3.4.1. Opportunity 1
3.5. Attractive Investment Proposition, by Geography, 2016
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Stem Cells Market, by Product, 2015-2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Stem Cells Market, by Product, 2016
4.2. Adult Stem Cells
4.2.1. Neuronal Stem Cells
4.2.2. Hematopoietic Stem Cells
4.2.3. Mesenchymal Stem Cells
4.2.4. Umbilical Cord Stem Cells
4.2.5. Others
4.3. Human Embryonic Stem Cells
4.4. Induced Pluripotent Stem Cells
4.5. Very Small Embryonic Like Stem Cells

Chapter 5. Global Stem Cells Market, by Application, 2015-2025 (US$ Mn)
5.1. Overview
5.2. Regenerative Medicine
5.3. Neurology
5.3.1. Orthopedics
5.3.2. Oncology
5.3.3. Hematology
5.3.4. Cardiovascular Diseases
5.3.5. Diabetes
5.3.6. Liver Disorders
5.3.7. Others
5.4. Drug Discovery and Development

Chapter 6. Global Stem Cells Market, by Therapy, 2015-2025 (US$ Mn)
6.1. Overview
6.2. Autologous Stem Cell Therapy
6.3. Allogeneic Stem Cell Therapy

Chapter 7. Global Stem Cells Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Stem Cells Market, 2015 – 2025
7.2.1. North America Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
7.2.2. North America Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
7.2.2.1. U.S.
7.2.2.2. Canada
7.3. Europe Stem Cells Market, 2015 – 2025
7.3.1. Europe Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
7.3.2. Europe Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
7.3.2.1. U.K.
7.3.2.2. Germany
7.3.2.3. France
7.3.2.4. Rest of Europe
7.4. Asia Pacific Stem Cells Market, 2015 – 2025
7.4.1. Asia Pacific Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
7.4.2.1. Japan
7.4.2.2. China
7.4.2.3. India
7.4.2.4. Rest of Asia Pacific
7.5. Latin America Stem Cells Market, 2015 – 2025
7.5.1. Latin America Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
7.5.2.1. Brazil
7.5.2.2. Mexico
7.5.2.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Stem Cells Market, 2015 – 2025
7.6.1. Middle East & Africa Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
7.6.2. Middle East & Africa Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
7.6.2.1. GCC
7.6.2.2. Rest of Middle East and Africa

Chapter 8. Company Profiles
8.1. Advanced Cell Technology, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. News Coverage
8.2. BIOTIME, Inc.
8.3. BrainStorm Cell Therapeutics
8.4. Caladrius
8.5. Cellartis AB
8.6. Celgene Corporation
8.7. CellGenix GmbH
8.8. Gamida Cell
8.9. Genea BioCells
8.10. Lonza
8.11. PromoCell GmbH
8.12. Pluristem
8.13. TiGenix
8.14. Waisman Biomanufacturing

List Of Table :

TABLE 1 Global Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 2 Global Stem Cells Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 3 Global Stem Cells Market, by Therapy, 2015 – 2025 (US$ Mn)
TABLE 4 Global Stem Cells Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 5 North America Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 6 North America Stem Cells Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 7 North America Stem Cells Market, by Therapy, 2015 – 2025 (US$ Mn)
TABLE 8 North America Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Stem Cells Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Stem Cells Market, by Therapy, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Stem Cells Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Stem Cells Market, by Therapy, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Stem Cells Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Stem Cells Market, by Therapy, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Stem Cells Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East and Africa Stem Cells Market, by Product, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East and Africa Stem Cells Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East and Africa Stem Cells Market, by Therapy, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East and Africa Stem Cells Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 25 Advanced Cell Technology, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 BIOTIME, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 BrainStorm Cell Therapeutics: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Caladrius: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Cellartis AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 Celgene Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 CellGenix GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Gamida Cell: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Genea BioCells: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Lonza: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 PromoCell GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Pluristem: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 TiGenix: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 Waisman Biomanufacturing: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List Of Figure :

FIG. 1 Stem Cells: Market Segmentation
FIG. 2 Global Stem Cells Market Share, by Product, 2016 (Value %)
FIG. 3 Global Stem Cells Market Share, by Application, 2016 (Value %)
FIG. 4 Global Stem Cells Market Share, by Therapy, 2016 (Value %)
FIG. 5 Global Stem Cells Market Share, by Geography, 2016 (Value %)
FIG. 6 Attractive Investment Proposition, by Geography
FIG. 7 Market Competition Landscape, by Key Players, 2016
FIG. 8 Global Adult Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 9 Global Neuronal Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 10 Global Hematopoietic Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 11 Global Mesenchymal Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 12 Global Umbilical Cord Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 13 Global Others Adult Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 14 Global Human Embryonic Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 15 Global Induced Pluripotent Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 16 Global Very Small Embryonic Like Stem Cells Market 2015 – 2025 (US$ Mn)
FIG. 17 Global Regenerative Medicine Market 2015 – 2025 (US$ Mn)
FIG. 18 Global Neurology Market 2015 – 2025 (US$ Mn)
FIG. 19 Global Orthopedics Market 2015 – 2025 (US$ Mn)
FIG. 20 Global Oncology Market 2015 – 2025 (US$ Mn)
FIG. 21 Global Hematology Market 2015 – 2025 (US$ Mn)
FIG. 22 Global Cardiovascular Diseases Market 2015 – 2025 (US$ Mn)
FIG. 23 Global Diabetes Market 2015 – 2025 (US$ Mn)
FIG. 24 Global Liver Disorders Market 2015 – 2025 (US$ Mn)
FIG. 25 Global Others Regenerative Medicine Market 2015 – 2025 (US$ Mn)
FIG. 26 Global Drug Discovery and Development Market 2015 – 2025 (US$ Mn)
FIG. 27 Global Autologous Stem Cells Therapy Market 2015 – 2025 (US$ Mn)
FIG. 28 Global Allogeneic Stem Cells Therapy Market 2015 – 2025 (US$ Mn)
FIG. 29 U.S. Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 30 Canada Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 31 U.K. Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 32 Germany Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 33 France Stem Cells Market, 2015-2025 (US$ Mn)
FIG. 34 Rest of Europe Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 35 Japan Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 36 China Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 37 India Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 38 Rest of Asia Pacific Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 39 Brazil Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 40 Mexico Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 41 Rest of Latin America Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 42 GCC Stem Cells Market, 2015 – 2025 (US$ Mn)
FIG. 43 Rest of Middle East and Africa Stem Cells Market, 2015 – 2025 (US$ Mn)

Based on product, the global stem cell market is categorized into

• Adult Stem Cells
  • Neuronal Stem Cells
  • Hematopoietic Stem Cells
  • Mesenchymal Stem Cells
  • Umbilical Cord Stem Cells
  • Others
• Human Embryonic Stem Cells
• Induced Pluripotent Stem Cells
• Very Small Embryonic Like Stem Cells

The stem cell market is driven by factors such as rising demand for epigenetics for drug discovery and development, and development of cellular models to provide better understanding of disease mechanism. In addition the stem cells are a repository of information regarding the cellular differentiation, tissue homeostasis, and molecular processes. In 2016, adult stem cells segment held the largest market share mainly due to factors such as high compatibility with human body, low contamination while subculturing and other advantages such as avoiding ethical issues associated with the use of other human cells. Induced pluripotent stem cells will be the fastest growing market throughout the forecast period 2017-2025 majorly due to its application in regenerative medicines, drug screening, disease modelling and organoid generation. The major players in stem cell market are Advanced Cell Technology, Inc., BIOTIME, Inc., BrainStorm Cell Therapeutics, Caladrius, Cellartis AB, Celgene Corporation, CellGenix GmbH, Gamida Cell, Genea BioCells, Lonza, PromoCell GmbH, Pluristem, TiGenix and Waisman Biomanufacturing.

Based on application, the global stem cells market is categorized into

• Regenerative Medicine
  • Neurology
  • Orthopedics
  • Oncology
  • Hematology
  • Cardiovascular Diseases
  • Diabetes
  • Liver Disorders
  • Others
• Drug Discovery and Development

In 2016, regenerative medicine dominated the market mainly due to factors such as rising prevalence of chronic disease requiring immediate medical intervention, and it provides novel opportunities to the pharmaceutical companies by identification of lead candidate and development of novel drugs. In addition, there is supportive regulatory environment for the utilization of stem cells as regenerative medicine. The drug discovery and development segment is anticipated to register faster growth throughout the forecast period 2017-2025, mainly due to increasing demand for stem cell technology by the pharmaceutical giants to reduce the high attrition rate of late stage drug candidates and build innovative cellular models. Moreover, the constantly evolving methodologies for the isolation of stem cells has led to the advancement of high throughput and combinatorial screening technologies thus supplementing in drug discovery and development.

Based on therapy, the global stem cells market is categorized into:

• Autologous Stem Cells Therapy
• Allogenic Stem Cells Therapy

In 2016, the autologous stem cell therapy segment held the largest market share chiefly due to factors such as high body compatibility, no immunological rejection. Additionally it can take place outside the operating room without giving anesthesia. The limitation of the autologous stem cell therapy are that the patient needs to be in close proximity of the hospital or research center, it is a non-scalable technique and enrolls only small patient population. Allogenic stem cell therapy will be the fastest growing market throughout the forecast period 2017-2025 majorly due to its application in oncology as it gives the graft versus cancer effect in which the donor cells make their own immune cells which helps in destroying any cancer cells remaining after high dose treatment. Additionally the donor could be asked to donate more stem cells and white blood cells whenever required. The limitation of this therapy is the graft versus host disease where the donor immune cells attacks the host healthy cells and the risk of infection even though the donors are tested before, as the infections surface after the allogenic transplant as the host immune system is suppressed due to immunosuppressive drugs.

For the purpose of this study, the global stem cells market is categorized into the following regional and country specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

North America was observed to be the largest market for stem cells in the base year 2016. The dominance of North America is mainly attributed to the rising prevalence of chronic diseases, enhanced government spending in the research and development facilities in healthcare institutions and affordable reimbursement scenario. The market growth in Europe is mainly attributed to the rising demand for epigenetics and its application in biomedical science. Increasing popularity of personalized medication and large number of clinical trials conducted on therapeutic application of stem cells in treating hematological disorders. Asia Pacific was observed as the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth are presence of geriatric population suffering with chronic diseases requiring immediate medical intervention, technological advancement in the extraction and harvesting of stem cells for therapeutic applications and supportive regulatory environment for stem cells products. Moreover, factors such as developing health infrastructure, untapped market in remote areas with unmet medical needs are going to fuel the rapid growth of stem cells market in Latin America, and Middle East and Africa in the near future.